Twitter   LinkedInFacebook RSS  
  • BRCA
  • DXX-1
  • Cell Culture
  • DXX-2
  • Roche-sequencer
  • DXX-3
Diagnostics World Preview of the Next Generation Diagnostics Summit
| Diagnostics World News | Diagnostics World News will be attending the Next Generation Diagnostics Summit in Washington, D.C. this August, and we are looking forward to four days filled with diagnostics challenges, solutions, and advances. The Summit includes 13 different conference programs, and here is just some of what we have highlighted. more

Theranos Last Defense Crumbles
| Forbes | Until now, Theranos and those close to the company could claim that its problems were limited to its laboratory in Newark, California, and that it had really done a fine job in Arizona, where most of its testing centers are. That claim lies demolished. more

Foundation Medicine Awarded Patent for Dx Test
| Diagnostics World Brief | Foundation Medicine, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. patent number 9,340,830, entitled, “Optimization of Multigene Analysis of Tumor Samples.” The patent, which is assigned to Foundation Medicine, includes fundamental claims describing methods of analyzing a cancer patient’s tissue or blood specimen to detect multiple classes of genomic alterations. more

FDA Issues Draft Guidance on NGS Sequencing for Infectious Disease Diagnostics
| RAPS | FDA is proposing to regulate genetic sequencing diagnostic tests as complete systems that encompass all processes from specimen collection through clinical results. more

Embattled Blood Lab Theranos Makes a Bid to Regain Confidence
| The New York Times | The blood-testing company, which is under criminal investigation, is replacing its chief operating officer and expanding its board. more

DIY Blood Tests? Theres A Downside To Ordering Your Own Shots
| NPR.org | It's legal to order diagnostic blood tests without consulting a doctor in many states. But critics say healthy patients can go down a rabbit hole of invasive assays and unnecessary treatments. more

Community BRCA Testing Initiative at Halfway Point
| Diagnostics World An area-wide genetic testing initiative in Alabama is six-months in, and more than 1,000 test kits have been processed. About 4% of the tests have returned mutations. more

Urine test may make Zika detection easier
| STAT | US health officials say urine testing is more likely than blood testing to detect Zika virus infection in many patients. more

Researchers Develop Low-Cost Paper Diagnostic Test For Zika Virus
| Forbes | This low-cost paper diagnostic test can show the results of the Zika virus in under an hour. Researchers from the Wyss Institute at Harvard University say the test is as easy to read as a home pregnancy test. more

Everything You Need to Know About the Theranos Saga So Far
| WIRED | Theranos is a complicated, secretive company caught up in a fascinating, confusing scandal about medical accuracy and ethics. Let's start at the beginning. more


Quanterix Opens Call for Proposals for Second Annual Accelerator Grant Program Focused on Oncology and Liquid Tumor Biopsy Technology
| BOSTON, MA, UNITED STATES - May 20, 2016 - Quanterix Corporation, a leader in the transformation of healthcare through its ultrasensitive single molecule testing capabilities, today announced the recipient of its first annual Accelerator Grant Program and a call for proposals for its second grant, focused on oncology research more

Definiens’ Symposium Finds Tissue Context of Tumor is Key to Cancer Immunotherapy Success
| MUNICH, GERMANY - May 10, 2016 - Definiens, the pioneer in Tissue Phenomics® solutions for diagnostics development, has announced findings from the International Symposium, a sold-out gathering of international researchers and clinicians on April 27-28 in Boston, Massachusetts to discuss advancements in oncology and the application of Tissue Phenomics more

Novigenix publishes multi-center study of Colox(R) in Clinical Cancer Research
| LAUSANNE, SWITZERLAND - May 9, 2016 - Novigenix SA today announced the publication of a clinical validation study of Colox in the highly ranked journal  Clinical Cancer Research more

BARTS PATIENT DATA DEMONSTRATES POTENTIAL OF PARSORTIX FOR PROSTATE CANCER DETECTION CLINICAL APPLICATION
| LONDON, UK - Mar 21, 2016 - ~~For immediate release  21 March 2016 ANGLE plc (“the Company”) BARTS PATIENT DATA DEMONSTRATES POTENTIAL OF PARSORTIX FOR PROSTATE CANCER DETECTION CLINICAL APPLICATION Potential for a simple blood test to not only detect prostate cancer but also to assess the aggressiveness of the disease allowing risk stratification to active surveillance or intervention ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is delighted to announce that the results of Barts Cancer Institute’s ongoing work with ANGLE’s Parsortix system have provided evidence in support of the use of Parsortix in the detection and assessment of prostate cancer more

Definiens Launches Immunoprofiling Panel to Rapidly Screen Tissue Samples for Immune Responses
| MUNICH, GERMANY - Mar 8, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of a new service, the Immunoprofiling Panel, to enable pharmaceutical companies, companion diagnostic developers and academic research centers working in immuno-oncology to quickly screen their target biomarkers and measure immune response more

IMMray™ PanCan-d detects 98% of pancreatic cancers in retrospective study with 1400 blood samples
| LUND, SWEDEN - Dec 4, 2015 -     LUND, Sweden  ― CREATE Health Translational Cancer Center, Lund, Sweden in collaboration with Immunovia today announced that they have completed a retrospective study demonstrating that the IMMray™ PanCan-d test is able to differentiate with 96% accuracy patients with  early resectable stages of pancreatic cancer, stage I and II, from the healthy controls more

Insight Pharma Reports Announces Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system
| NEEDHAM, MA, UNITED STATES - Oct 14, 2015 - For more information:Dan MillerInsight Pharma Reportsdmiller@healthtech.com781-972-5492 FOR IMMEDIATE RELEASE Insight Pharma Reports Announces Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system
NEEDHAM, MASS more

Insight Pharma Reports’ The Human Microbiome Report
| NEEDHAM, MA, UNITED STATES - Jun 19, 2015 - Insight Pharma Reports' releases the report, The Human Microbiome: Biomedical Implications and Birth of a Market, which covers the evolution of microbiome research and its growth in the commercial market more

Insight Pharma Reports Releases Marketing to Life Scientists Study
| NEEDHAM, MA, UNITED STATES - Jun 19, 2015 - Insight Pharma Reports, a division of Cambridge Healthtech Institute, releases a new market study focusing on marketing to life scientists more



Lead Generation




For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.